4. Notes Payable (Tables)

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Schedule of notes payable

	September 30, 2016			December 31, 2015
Loan payable under prepaid forward purchase contract	$	5,000,000		$	–
Loan payable to TCA Global Master Fund, LP ("TCA") in the principal amount of $3,000,000 at 16% interest, with interest only payments through September 11, 2016 (the "TCA Debenture"). Principal and interest payments due monthly from October 11, 2016 through September 11, 2017		3,000,000			3,000,000
Notes payable to CommerceNet and Jay Tenenbaum in the original principal amount of $500,000, bearing interest at 6% per annum (the "Tegal Notes"). Principal and interest payments are made annually from July 12, 2015 through July 12, 2017		341,612			341,612
Loan payable to former shareholder of Epinex Diagnostics Laboratories, Inc. in the original principal amount of $400,000, at 0% interest, with principal payments due in periodic installments of $100,000 from November 26, 2014 through February 26, 2016 (the "Epinex Note")		–			100,000
Other convertible notes payable		440,000			–
Unamortized discount on TCA Debenture		(252,879	)		(453,025	)
Unamortized discount on Epinex Note		–			(1,775	)
Unamortized discount on other convertible notes		(403,536	)		–
Derivative liability associated with the TCA Debenture, at fair value		402,996			186,117
		8,528,193			3,172,929
Less current portion		(8,528,193	)		(269,031	)
Notes payable - third parties, net of current portion	$	–		$	2,903,898

Schedule of notes payable - related parties

	September 30, 2016		December 31, 2015
Convertible debenture dated December 31, 2014 which bears interest at 10% per annum and was due December 31, 2016 (the "D&D Debenture"). The lender, D&D Funding II, LLC, had the option to convert the note into the Company's common stock at a 25% discount to the average trading price (as defined in the note agreement) for ten consecutive trading days prior to the conversion date	$	–	$	3,000,000
Loan payable to Alcimede LLC, bearing interest at 6% per annum, with all principal and interest due on February 2, 2017		218,500		500,000
Loan payable to Christopher Diamantis		500,000		1,600,000
Other advances from related parties		650,000		–
Unamortized discount on D&D Debenture		–		(2,236,112	)
Derivative liabilities associated with the D&D Debenture, at fair value		–		2,270,000
Total notes payable, related parties	$	1,368,500	$	5,133,888